The Pharma Data

DECEMBER 1, 2020

01, 2020 (GLOBE NEWSWIRE) — Allena Pharmaceuticals, Inc. 333-228656) previously filed with the Securities and Exchange Commission (the “SEC”) on December 3, 2018, and declared effective by the SEC on December 26, 2018. About Allena Pharmaceuticals Allena Pharmaceuticals, Inc. NEWTON, Mass.,

Pharmaceuticals 52

Pharmaceuticals Clinical Trials Trials Clinical Development 52

The Pharma Data

JANUARY 27, 2021

27, 2021 — The number of adverse drug reactions (ADRs) associated with hydroxychloroquine and chloroquine more than doubled in 2020 compared with 2018 and 2019, according to a research letter published online Jan. 1, 2018, to Sept. percent in 2018 and 2019, respectively. percent in 2018 and 2019, respectively.

Drugs 52

Drugs Hospitals International Pharmaceuticals 52

Drug Patent Watch

JULY 26, 2023

This chart shows the generic pharmaceutical companies that had the most successful drug patent challenges from 2018 to 2023. Companies that successfully challenge patents on branded drugs are granted six… The post Most prolific drug patent challengers appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 52

Pharmaceutical Companies Drugs Pharmaceuticals 52

The Pharma Data

NOVEMBER 1, 2020

02, 2020 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) announces it has entered into a strategic licence and commercial partnership with China Grand Pharmaceutical and Healthcare Holdings Limited (‘China Grand Pharma’) for Telix’s portfolio of Molecularly-Targeted Radiation (‘MTR’) products.

Pharmaceuticals 40

Pharmaceuticals Marketing Production Therapies 40

Drug Target Review

OCTOBER 31, 2023

Ashley Hall, CDO of Reneo Pharmaceuticals Throughout my education I was discouraged by many around me. How did that transfer into the pharmaceutical industry? This sector of the pharmaceutical industry combined both my science and law background. Reneo has been working on this since before 2018.

Cell Biology 108

Cell Biology Pharmaceuticals Science Disease 108

The Pharma Data

DECEMBER 2, 2020

Kazumi was also a co-founder and CEO of Mitobridge, a start-up company developing mitochondrial drugs for the treatment of muscle and kidney diseases, until its acquisition by Astellas Pharma in 2018. Lisa is a senior pharmaceutical executive with more than 20 years of experience in research and drug discovery. 3, 2020 08:00 UTC.

Pharmaceuticals 52

Pharmaceuticals Synthetic Chemistry RNA Disease 52

The Pharma Data

AUGUST 17, 2020

Amazon has entered the pharmaceutical market by launching ‘Amazon Pharmacy’ in India. . Amazon first entered pharmaceuticals in 2017, and bought the home pharmaceutical delivery service ‘PilPack’ in 2018. Amazon first entered pharmaceuticals in 2017, and bought the home pharmaceutical delivery service ‘PilPack’ in 2018.

Pharmacy 52

Pharmacy Pharmaceuticals Marketing Drugs 52

Drug Target Review

JUNE 19, 2024

Also, many companies never reached the point where they received validation from big pharmaceutical companies. Prior to joining Lineage, Mr Culley served from August 2017 to September 2018 as interim Chief Executive Officer at Artemis Therapeutics, Inc. Mr Culley served on the Board of Orphagen Pharmaceuticals, Inc.

Therapies 84

Therapies Small Molecule Pharmaceutical Companies Molecular Biology 84

The Pharma Data

JULY 15, 2021

JJIPO@Monash was originally launched in 2018 to provide crucial support to researchers and companies in the Victorian life-science sector as part of the Government’s commitment to the medical technologies and pharmaceuticals sector – one of eight priority growth sectors.

Government 52

Government Science Pharmaceuticals Pharmaceutical Companies 52

Drug Target Review

SEPTEMBER 26, 2023

2018 Mar;17(3):167–81. 2018 Dec 11;94(10):390–411. 2018;(136):56573. Gaps and challenges in nonclinical assessments of pharmaceuticals: An FDA/CDER perspective on considerations for development of new approach methodologies. Morgan P, Brown DG, Lennard S, Anderton MJ, Barrett JC, Eriksson U, et al. Nat Rev Drug Discov.

Drugs 112

Drugs FDA Disease Animal Testing 112

Drug Target Review

OCTOBER 11, 2023

Small molecules have been the mainstay of the pharmaceutical industry for nearly a century, they are easy to deliver – they are often given orally – and our health systems have a lot of experience of working with them. 2018 [cited 2023 Sep 5]. Autophagy boosters, in contrast, are conventional small molecule drugs. cited 2023 Sep 5].

Disease 113

Disease Treatment Small Molecule Therapies 113

The Pharma Data

MAY 3, 2021

This repurchase authorization is in addition to the authorization remaining under the share repurchase program authorized by the Board in June 2018. As of March 31, 2021 , there was $1 billion remaining under the 2018 share repurchase program. Purchases may be made from time to time at management’s discretion.

Pharmaceuticals 52

Pharmaceuticals Disease Marketing Research 52

Drug Target Review

MARCH 3, 2025

However, promising pilot data from ongoing collaborations with pharmaceutical companies suggest that brain organoids are set to become a valuable tool in preclinical research. Prior to this, he was co-founder and CSO of Braingineering Technologies SARL (2016-2018).

Disease 52

Disease Treatment Therapies Cell Biology 52

The Pharma Data

NOVEMBER 25, 2020

Vifor Pharma Group is a global pharmaceuticals company. The company is a partner of choice for pharmaceuticals and innovative patient-focused solutions. The company develops, manufactures and markets pharmaceutical products for precision patient care. 12 June 2018. Last accessed: June 2018.

International 52

International Pharmaceuticals Disease Pharmaceutical Companies 52

The Pharma Data

NOVEMBER 2, 2020

GW Pharmaceuticals hopes to bring its cannabis-based treatment for multiple sclerosis spasticity to the United States. Justin Gover, chief executive officer of GW Pharmaceuticals, proclaimed his excitement about launching the Phase III study in the United States. Sativex is approved for use in parts of Europe for this indication.

FDA Approval 52

FDA Approval Marketing FDA Drugs 52

The Pharma Data

DECEMBER 18, 2020

during 2018 at a single transplant center. Several authors disclosed financial ties to the pharmaceutical industry. Molnar, M.D., The researchers observed no differences between the HCV+ and HCV? Abstract/Full Text (subscription or payment may be required). © 2020 HealthDay. All rights reserved. Posted: December 2020.

Virus 52

Virus Science Pharmaceuticals Disease 52

The Pharma Data

MARCH 17, 2022

Alexion, AstraZeneca’s Rare Disease group, has entered into a settlement agreement with Chugai Pharmaceutical Co., Ultomiris patent proceedings US In November 2018, Chugai filed a lawsuit against Alexion in the Delaware District Court alleging that Ultomiris infringes US patent No. No further amounts are payable by either party.

Disease 52

Disease Treatment Pharmaceuticals Science 52

Drug Target Review

OCTOBER 23, 2024

However, many pharmaceutically relelvant targets remain ‘undruggable’. Limitations of DNA-encoded chemical libraries in drug discovery DNA-encoded chemical libraries (DEL) are widely used in the pharmaceutical industry for drug discovery of small molecules. 2018 Jun 20;87(1):479–502. 2022 May 25;76(5):388. 3 Neri D, Lerner RA.

Small Molecule 65

Small Molecule DNA Drugs Pharmaceuticals 65

The Pharma Data

DECEMBER 10, 2020

ATLANTA, GA, December 10, 2020 /24-7PressRelease/ — The law firm of Schneider Hammers has filed numerous lawsuits against Teva Pharmaceuticals USA, Inc., Teva Women’s Health, LLC, Teva Women’s Health, Inc., The Cooper Companies, Inc., and CooperSurgical, Inc. Several other plaintiffs have similar stories.

Production 52

Production Pharmaceuticals 52

The Pharma Data

NOVEMBER 16, 2020

Cases with knee replacement (KR) or hip replacement (HR) between 2014 and 2018 were identified; each case was age- and gender-matched with up to four controls (913 cases and 3,652 controls, respectively). ” One author disclosed financial ties to the pharmaceutical industry. Priyanka Ballal, M.D., Press Release. More Information.

Pharmaceuticals 52

Pharmaceuticals Research 52

The Pharma Data

JULY 28, 2021

Additionally, Viviane Monges will join EUROAPI, a future leading European company dedicated to the development, production, and marketing of active pharmaceutical ingredients (API), as an independent non-executive Chair of the Supervisory Board. At Wyeth Pharmaceuticals/Pfizer she served as CFO of the Global Pharma Business unit.

Pharmaceutical Companies 52

Pharmaceutical Companies International Pharmaceuticals Compliance 52

New Drug Approvals

SEPTEMBER 13, 2024

4] [6] Aticaprant was originally developed by Eli Lilly , was under development by Cerecor for a time, and is now under development by Janssen Pharmaceuticals. [2] 21] In August 2017, it was announced that Cerecor had sold its rights to aticaprant to Janssen Pharmaceuticals. [22] 30 January 2018. nM vs. 24.0 nM vs. 24.0

Treatment 62

Treatment Clinical Trials Pharmacokinetics Pharmaceuticals 62

The Pharma Data

OCTOBER 14, 2020

15, 2020 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. President and Chief Executive Officer of Tonix Pharmaceuticals. 2018) PLoS One. About Tonix Pharmaceuticals Holding Corp. Jessica Morris (corporate) Tonix Pharmaceuticals investor.relations@tonixpharma.com (212) 688-9421.

Vaccine 40

Vaccine Pharmaceuticals Small Molecule Virus 40

The Pharma Data

JUNE 17, 2022

“By committing to bring biosimilar formulations such as Hyrimoz citrate-free HCF to patients, we are serving a critical need in expanding access to important medicines and fueling pharmaceutical innovation.”. About Sandoz Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars.

Biosimilars 52

Biosimilars Pharmacokinetics FDA Approval Packaging 52

New Drug Approvals

JANUARY 31, 2024

The prevalence of non-alcoholic steatohepatitis (NASH), a form of NAFLD that is associated with hepatic inflammation and ballooning of hepatocytes, is expected to increase by 63% between 2015 and 2030 in the United States (Estes, Hepatology, 2018; 67(1): 123-133), where NASH is expected to become the leading cause of liver transplantation by 2020.

Treatment 52

Treatment Disease Pharmaceuticals Drugs 52

The Pharma Data

DECEMBER 17, 2020

Buvidal received market authorizations in EU and Australia in November 2018. Camurus’ clinical pipeline includes products for the treatment of cancer, endocrine diseases, pain and addiction, which are developed in-house and in collaboration with international pharmaceutical companies. 2018; 178(6):764-773.

Treatment 52

Treatment Clinical Trials International Pharmaceutical Companies 52

The Pharma Data

JANUARY 14, 2021

Dr. Dickstein enjoyed 30 years in the pharmaceutical field before retiring in 1998 as the vice president of clinical research for Transcend Therapeutics, Inc. Dickstein remains a pharmaceutical consultant in his hometown of Cohasset, Massachusetts, since 1999.

Laboratories 52

Laboratories Clinical Research Hospitals Pharmaceuticals 52

The Pharma Data

JUNE 28, 2021

“Bayer is focused on addressing the various medical needs of cancer patients, providing treatments that improve patient outcomes throughout the different stages of the disease,” said Robert LaCaze, Member of the Executive Committee of the Pharmaceuticals Division and Head of the Oncology Strategic Business Unit at Bayer.

Small Molecule 52

Small Molecule Licensing Licensing Therapies 52

The Pharma Data

AUGUST 1, 2021

Takeda Pharmaceutical Company Limited today announced the receipt of a decision by the Irish Tax Appeals Commission on July 30, 2021 (IST) to uphold the Irish Revenue Commissioners’ position related to the treatment of a break fee received by Shire plc (“Shire”) in October 2014 from AbbVie Inc. Shire was acquired by Takeda in January 2019.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Treatment 52

New Drug Approvals

SEPTEMBER 8, 2024

2] Palopegteriparatide was granted an orphan drug designation by the US Food and Drug Administration (FDA) in 2018, [7] and by the EMA in 2020. [8] “International nonproprietary names for pharmaceutical substances (INN): recommended INN: list 86” WHO Drug Information. 48,000) consisting of 34 amino acid residues.

FDA 62

FDA International Trials FDA Approval 62

The Pharma Data

JANUARY 6, 2021

UNION therapeutics A/S is a privately held, clinical stage, pharmaceutical company dedicated to the development of novel treatments for inflammatory and infectious diseases. 2018)2: Menter MA, Armstrong AW, Gordon KB, Wu JJ. 2018 Feb;37(2S):S48-S51. About UNION therapeutics A/S. Sources 1: Li et al. Semin Cutan Med Surg.

FDA Approval 52

FDA Approval FDA Clinical Development Clinical Research 52

The Pharma Data

APRIL 6, 2022

” Integrating Pharmaceuticals and Oncology business units. Novartis will integrate the Pharmaceuticals and Oncology business units and create two separate commercial organizations with a stronger geographic focus – Innovative Medicines US and Innovative Medicines International.

International 52

International Pharmaceuticals Drug Development Marketing 52

FDA Law Blog: Biosimilars

JULY 18, 2023

Claud — The Office of Pharmaceutical Quality (OPQ), located within FDA’s Center for Drug Evaluation and Research (CDER), uses global inspection, surveillance, policy, and research activities to set quality standards for drugs. Consistent with that initiative, OPQ recently issued its 2022 Annual Report on the State of Pharmaceutical Quality.

FDA 52

FDA Licensing Licensing Laboratories 52

The Pharma Data

SEPTEMBER 9, 2020

Ondexxya was originally developed by Portola Pharmaceuticals, which was acquired by Alexion in July this year. The drug secured approval from the European Commission in April 2019 and from the FDA in May 2018. This is a positive step forward for the safety of patients being treated with these important and widely used drugs.”.

Treatment 40

Treatment FDA Therapies Pharmaceuticals 40

Common Sense for Drug Policy Blog

JUNE 6, 2024

2018 ; Llewellyn and Tober 2010; Denham 2019 ). Underground labs can be defined as illicit operations where IPEDs, most commonly anabolics androgenic steroids, are produced from these imported powders outside of registered pharmaceutical manufacture. 2017 ; Greenway and Price 2018 ). 2014 ; Begley et al. 2014 ; Begley et al.

Marketing 40

Marketing Drugs Production Pharmaceuticals 40

The Pharma Data

DECEMBER 3, 2020

He also served as CFO at Aralez Pharmaceuticals Inc. Prior to UroGen, Pfreudschuh was the CFO of Sucampo Pharmaceuticals Inc., Monti has served as president and CEO of Pherin Pharmaceuticals. Bradshaw most recently served as CSO for Arrowhead Pharmaceuticals. and spent 11 years at Sanofi in a variety of financial roles.

Pharmaceuticals 52

Pharmaceuticals Clinical Development Medical Schools Pharmacy 52

The Pharma Data

JANUARY 21, 2021

Caggiano joins Evolve Biologics after most recently serving as CEO of Dendreon Pharmaceuticals LLC. Among his earlier leadership roles in the biotech, pharmaceutical and medical device industries, Caggiano directed the divestiture of Allergan’s LAP-BAND to Apollo Endosurgery in 2013. Abbott Laboratories and TAP Pharmaceuticals.

Laboratories 52

Laboratories Pharmaceuticals Engineering Clinical Development 52